Documentos de Académico
Documentos de Profesional
Documentos de Cultura
PRESENTER:
DAINY THOMAS MSc NURSING IST YEAR STUDENT, AIIMS.
MODERATOR:
MADAM RACHEL ANDREWS LECTURER, AIIMS.
INTRODUCTION
OBJECTIVES
Define cardiomyopathy. Explain the types of cardiomyopathy. List down the etiological factors. Describe the pathophysiology of cardiomyopathy. Enlist the clinical features. Explain the medical and surgical management. Discuss the nursing management.
LAYERS OF HEART
Definition
Diseases that involve the myocardium primarily and are not the result of hypertension, or congenital, valvular, coronary or arterial or pericardial abnormalities.
Cardiomyopathy
-"heart
muscle
disease"
deterioration of the function of the myocardium (i.e., the actual heart muscle) for any reason.
Definition
Disease of the heart muscle in which the heart loses its ability to pump blood effectively. Heart muscle- enlarged or abnormally thick or rigid. Rare cases- heart muscle tissue- replaced with scar tissue. Disease progresses heart becomes weaker and less able to pump blood to heart failure, arrhythmias, systemic and pulmonary edema and, more rarely, endocarditis.
Incidence
3rd most common form of heart disease in U.S. 2nd most common cause of adolescent sudden death. Directly affects cardiac structure and
Classification
Extrinsic or Intrinsic cardiomyopathy . Extrinsic - primary pathology - outside the myocardium itself.
Classification
Intrinsic - Weakness in the heart muscle that is not due to an identifiable external cause (idiopathic cardiomyopathies).
Dilated cardiomyopathy (DCM) Hypertrophic cardiomyopathy (HCM) Restrictive or constrictive cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Types
Primary/intrinsic cardiomyopathies
Genetic
Hypertrophic cardiomyopathy (HCM) Arrhythmogenic right ventricular
Types
Mixed
Dilated cardiomyopathy (DCM) Restrictive cardiomyopathy (RCM)
Acquired
Takotsubo cardiomyopathy Loeffler endocarditis
Secondary/extrinsic cardiomyopathies
Metabolic/storage
Amyloidosis Hemochromatosis
Endocrine
Diabetic cardiomyopathy Hyperthyroidism Acromegaly
Inflammatory
Chagas disease
Toxicity
Chemotherapy Alcoholic cardiomyopathy
"Ischemic cardiomyopathy
Neuromuscular
Muscular dystrophy
DILATED CARDIOMYOPATHY
Dilated Cardiomyopathy
Defined - a ventricular chamber exhibiting increased diastolic and systolic volumes and a low < 45% ejection fraction. Generally occurs - 20 to 60 years More common in men Heart muscle begins to dilate or stretch and become thinner Ventricular chamber size Over time, the heart becomes weaker Heart failure
Anatomical specimen
DILATED CMP
Hypertrophic Cardiomyopathy
Occurs when the heart muscle thickens abnormally (left ventricle) Obstructive type - septum thickens and bulges into the LV blocks the flow of blood into the aorta the ventricle must work much harder to pump blood past the blockage and out to the body. Symptoms - chest pain, dizziness, SOB, or fainting Can also affect the MV, causing blood to leak backward through the valve.
NonNon-obstructive type
-
The
entire
ventricle
may
become
thicker
(symmetric ventricular hypertrophy) or it may happen only at the bottom of the heart (apical hypertrophy).
-
Pathophysiology: Pathophysiology:
Left ventricular hypertrophy (thick ventricular wall) ventricular chamber size hold less blood CO pressure in the ventricles and lungs changes in the cardiac muscles interfere with the heart's electrical signals, leading to arrhythmias sudden cardiac arrest
Causes:
u
Inherited because of a gene mutation Develop over time because of high blood pressure or aging
Restrictive Cardiomyopathy
normal heart muscle with abnormal tissue, such as scar tissue ventricles cannot relax normally and expand to fill with blood atria to become enlarged blood flow in the heart is reduced complications - heart failure or arrhythmias occur.
Causes:
Radiation treatments, Infections, or Scarring after surgery Hemochromatosis Amyloidosis Sarcoidosis
Clinical Manifestations
Remain stable without symptoms. Signs and symptoms of heart failure (eg, dyspnea on exertion, fatigue). PND, cough (especially with exertion), and orthopnea. Fluid retention, peripheral edema, and nausea, (poor perfusion of GI system). Chest pain, palpitations, dizziness, nausea, and syncope with exertion. HCM- cardiac arrest -initial manifestation in young people, including athletes.
CLINICAL MANIFESTATIONS
Symptoms of heart failure Pulmonary congestion (left HF) Dyspnea (rest, exertional, nocturnal), Orthpnea Systemic congestion (right HF) Edema, Nausea, Abdominal pain, Nocturia Low cardiac output Fatigue and Weakness Hypotension, Tachycardia, Tachypnea, JVD If EF<20% high risk for embolism and SV arrhythmias
DIAGNOSIS
Cardiac catheterization Age >40, ischemic history, abnormal ECG LVEDV,LA, PCWP, RVEDV, RA, CVP
NORMAL
TREATMENT
Stop the disease from getting worse Reduce complications and the chance of sudden cardiac death
Medications:
Angiotensin-converting enzyme (ACE) inhibitors - lower blood pressure and reduce stress on the heart.
Beta-blockers- slow the heart rate by reducing the speed of the heart's contractions and also lower BP.
Calcium channel blockers- slow a rapid heartbeat by reducing the force and rate of heart contractions, decrease BP
Medications
the heartbeat.
Antiarrhythmics - keep the heart beating in a normal rhythm. Antibiotics- used before dental or surgical procedures, help to
prevent endocarditis.
Contd
Treatment of CCF Avoid dehydration Cardiac pacing Mx of arrhythmias ICD implantation Cardiac transplantation Stem cell transplantation
Lifestyle Changes
Quit smoking Lose excess weight Eat a low-salt diet Get moderate exercise, such as walking Avoid strenous exercise Fluid restriction, <2l/ day.
Lifestyle Changes
Avoid the use of alcohol and illegal drugs Get enough sleep and rest Reduce stress Treat underlying conditions, such as DM and high BP.
Removing the MV , chordae, and papillary muscles. MV then is replaced with a low-profile disk valve. Open-heart surgery for hypertrophic obstructive cardiomyopathy
Heart Transplantation
u
Orthotopic transplantation - most common Recipients heart- removed, donor heart is implanted at the vena cava and pulmonary veins.
Some remove the recipients heart leaving a portion of the recipients atria (with the vena cava and pulmonary veins) in place.
Orthotopic transplantation
u
Donor heart - implanted by suturing the donor atria to the residual atrial tissue of the recipients heart.
Both techniques then connect the recipients pulmonary artery and aorta to those of the donor heart.
Heterotopic transplantation
u
Less common. Donor heart - placed to the right and slightly anterior to the recipients heart.
Recipients heart -not removed. Transplanted heart - denervated Sympathetic and vagus nerves do not affect the transplanted heart.
Heterotopic transplantation
u
Resting rate of transplanted heart approx 70 - 90 bpm, increases gradually if catecholamines are in the circulation.
Patients gradually
and
Advanced age Poor blood circulation throughout the body Diseases of the kidney, lungs, or liver that can't be reversed. History of cancer or malignant tumors. Inability or unwillingness to follow lifelong medical
instructions
u
Pulmonary arterial hypertension that can't be reversed. Active infection throughout the body.
Organs are matched for blood type and size of donor and recipient.
Guidelines on how a donor heart is selected : The donor meet the legal requirement for brain death Consent forms are signed Younger than 65 years of age Have little or no history of heart disease or trauma to the chest Not exposed to hepatitis or HIV Donor heart must be transplanted within 4 hrs. After removal from the donor
the heart. The machine pumps blood through the patient's lungs and body while the diseased heart is removed and the donor heart is sewn into place.
u
Shortness of breath , Fever Fatigue , Weight gain Reduced amounts of urine Preventing Infection
Postoperative Course
Complex regimen of diet, medications, activity, follow-up laboratory studies, biopsies (to diagnose rejection), and clinic visits.
Patients
receive or
cyclosporine mycophenolate
or
tacrolimus, and
azathioprine
mofetil,
Complications
u
Rejection and infection Accelerated atherosclerosis of the coronary arteries (cardiac allograft vasculopathy [CAV]or accelerated graft atherosclerosis [AGA])
Hypertension Osteoporosis
Complications
u
Post transplantation lymphoproliferative disease Cancer - skin and lips Weight gain, obesity, diabetes, dyslipidemias (eg, hypercholesterolemia), hypotension, renal failure,
CNS,
respiratory,
and
GI
disturbances
Complications
u
Immunosuppressant medication toxicities Psychosocial stresses Guilt Anxiety about the new heart Depression or fear when rejection is identified Difficulty with family role changes
Patients in cardiogenic shock may benefit from a period of mechanical heart assistance.
Intra-aortic balloon pump- most common This pump decreases the work of the heart during contraction but does not perform the actual work of the heart.
extracorporeal membrane oxygenation (ECMO). Used for the patient whose heart cannot pump adequate blood through the lungs or the body.
VADs
u
Centrifugal VADs - external, nonpulsatile, coneshaped devices with internal mechanisms that spin rapidly, creating a vortex (tornado-like action) that pulls blood from a large vein into the pump and then pushes it back into a large artery.
Pneumatic VADsVADs
External or implanted pulsatile devices with a flexible reservoir housed in a rigid exterior.
Usually fills with blood drained from the patients atrium or ventricle.
It then forces pressurized air into the rigid housing, compressing the reservoir and returning the blood to the patients circulation, usually into the aorta.
Similar to the pneumatic VADs, But instead of pressurized air, one or more flat metal plates are pushed against the reservoir to return the blood to the patients circulation.
Designed to replace both ventricles. Some require the removal of the patients heart to implant the total artificial heart; others do not.
Temporary treatments while the patients own heart recovers or until a donor heart becomes available for transplantation (ie, bridge to transplant).
NURSING DIAGNOSES
u
u u u u
Decreased cardiac output related to structural disorders caused by cardiomyopathy or to dysrhythmia from the disease process and medical treatments. Diagnostic Assessment Review ECG Echocardiography Cardiac catheterization
Patient Monitoring
u
Monitor hourly urine output to evaluate effects of decreased intervention. cardiac output or pharmacologic
Analyze ECG rhythm strip at least every 4 hours and note rate.
Monitor
patient that
activities may
and adversely
nursing affect
interventions oxygenation.
Patient Assessment
u
Assess the patient for changes in neurological function hourly and as clinically indicated.
Assess
for
chest
discomfort
because
Assess heart and lung sounds to evaluate the degree in heart failure.
Patient Management
u
Provide liquid diet on acute phase, Administer diuretic as prescribed to reduce preload and afterload.
Monitor
serum
potassium
before
and
after
Prophylactic heparin may be ordered to prevent thromboembolus formation secondary to venous poisoning.
Institute
pressure
ulcer
prevention
strategies
Electrolyte monitoring Maintain an adequate hydration status Vigilant monitoring for tachycardias or dysrhythmias.
Emotional support, frequent teaching Counseling to assist in patient and family coping should be strongly encouraged.
Medic-alert bracelets are recommended Nitroglycerin and positive inotropic agents are not standard therapy in the patient with HCM.
Diuretics may be used, however, when initiated, close supervision of electrolyte and hydration status must be maintained.
Monitor for dysrhythmias - primary focus. Dehydrationand obstruction. preload and HR LVOTgradient
Restrict from playing competitive sports, the rationale should be explained thoroughly (i.e., complications secondary to dehydration and
Severe problems may also present after exercise when decreasing heart rate and vasodilatation occurs.
Make aware of the potential complications so they may take the necessary precautions.
Ineffective cardiopulmonary, cerebral, peripheral, and renal tissue perfusion related to decreased peripheral blood flow (resulting from decreased cardiac output)
Impaired gas exchange related to pulmonary congestion caused by myocardial failure (decreased cardiac output)
NURSING DIAGNOSES
Activity intolerance related to decreased cardiac output or excessive fluid volume, or both Anxiety related to the change in health status and in role functioning. Powerlessness related to disease process Noncompliance with medication and diet therapies
SUMMARY
u
Nursing care of the patient is composed of advocacy, emotional support, complication prevention, monitoring, and education. Consideration must be given to the presenting symptoms, lifestyle expectations, impact of treatment selection, risks, benefits, psychological implications, and insurance concerns. Therefore, the nurse must have understanding of the complexities of this disease and its varied treatment options to be able to provide the appropriate individualized care that all patients
CONCLUSION
BIBLIOGRAPHY
u u u